|
|
||||||||
Journal of Lipid Research, Vol 36, 383-392, Copyright © 1995 by Lipid Research, Inc.
JL Ellsworth, DB Lloyd, AJ Carlstrom and JF Thompson
Protein-DNA interactions within a region of the LDL receptor promoter
involved in sterol-mediated feedback repression of transcription were
examined using in vivo genomic footprinting with dimethylsulfate (DMS). A
broad region of protein-DNA contacts spanning from repeat 1 to beyond the
transcription start sites was observed in primary cultures of human skin
fibroblasts and hepatocytes. Hypermethylation of guanine -59 within the
sterol regulatory element-1 (SRE-1, repeat 2) occurred within a 4.0 h
incubation of fibroblasts with media containing lipoprotein-deficient serum
(LPDS) and cholesterol synthesis inhibitors. Methylation of this residue
was reduced to control levels within 2.0 h after the addition of a mixture
of 25-hydroxycholesterol and mevalonic acid. The time-dependent changes in
DMS-reactivity of guanine -59 induced by the cholesterol synthesis
inhibitors or oxysterols were paralleled by alterations in LDL receptor
mRNA. In contrast to the results with fibroblasts, neither cholesterol
synthesis inhibitors nor oxysterols produced consistent effects on the DMS-
reactivity of guanine -59 in hepatocytes despite induction or repression of
LDL receptor mRNA in these cells. Interestingly, no other changes in the
protection pattern over repeats 1, 2, and 3 were apparent in either
fibroblasts or hepatocytes. These results demonstrate that hypermethylation
of guainine -59 within the SRE-1 is positively associated with activation
of LDL receptor gene transcription in skin fibroblasts. Furthermore, the
absence of demonstrable changes in DMS-reactivity of other purines within
this region suggests that the LDL receptor promoter is poised to activate
transcription with only minimal changes of protein binding to the proximal
promoter in vivo.
ARTICLES
Protein binding to the low density lipoprotein receptor promoter in vivo is differentially affected by gene activation in primary human cells
Department of Atherosclerosis and Lipid Metabolism, Palo Alto Medical Foundation, CA 94301, USA.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Fink, J. Acimovic, T. Rezen, N. Tansek, and D. Rozman Cholesterogenic Lanosterol 14{alpha}-Demethylase (CYP51) Is an Immediate Early Response Gene Endocrinology, December 1, 2005; 146(12): 5321 - 5331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Peeters, M. J. Kotze, C. L. Scholtz, L. F. De Waal, D. C. Rubinsztein, G. A. Coetzee, G. Zuliani, R. Streiff, J. Liu, and D. R. van der Westhuyzen A 3-basepair deletion in repeat 1 of the LDL receptor promoter reduces transcriptional activity in a South African Pedi J. Lipid Res., May 1, 1998; 39(5): 1021 - 1024. [Abstract] [Full Text] |
||||
![]() |
K. D. Mehta, R. Chang, J. Underwood, J. Wise, and A. Kumar Identification of a Novel cis-Acting Element Participating in Maximal Induction of the Human Low Density Lipoprotein Receptor Gene Transcription in Response to Low Cellular Cholesterol Levels J. Biol. Chem., December 27, 1996; 271(52): 33616 - 33622. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Lloyd and J. F. Thompson Transcriptional Modulators Affect in Vivo Protein Binding to the Low Density Lipoprotein Receptor and 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Promoters J. Biol. Chem., October 27, 1995; 270(43): 25812 - 25818. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Kinyamu, C. J. Fryer, K. B. Horwitz, and T. K. Archer The Mouse Mammary Tumor Virus Promoter Adopts Distinct Chromatin Structures in Human Breast Cancer Cells with and without Glucocorticoid Receptor J. Biol. Chem., June 23, 2000; 275(26): 20061 - 20068. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |